Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet VIMAPRIL HL 10mg / 12.5mg tablets
- Product code:
- W13184002
- Quantity:
- 30
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- enalapril + hydrochlorothiazide (ACE inhibitor + diuretic)
- ATC
- C09BA02 — Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
The combination of Enalapril + hydrochlorothiazide is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalapril) with a thiazide diuretic (hydrochlorothiazide) to lower blood pressure.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart failure.
Side effects may include dizziness, dry cough, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.
The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart failure.
Side effects may include dizziness, dry cough, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.
Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.
General data about VIMAPRIL HL 10mg / 12.5mg
- Substance:
- enalapril + hydrochlorothiazide
- Date of latest medicines list:
- 01-07-2015
- Product code:
- W13184002
- Concentration:
- 10mg / 12.5mg
- Pharmaceutical form:
- tablets
- Quantity:
- 30
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for enalapril + hydrochlorothiazide
- 10mg/12.5mg
- 10mg/25mg
- 20mg/12.5mg